Autoantibodies immuno-mechanically modulate platelet contractile force and bleeding risk

Area of Science:

• Mechanobiology
• Immunology
• Integrin Biology
• Disease Pathophysiology

Background:

• Altered mechanotransduction is a proposed, yet under-evidenced, mechanism in disease.
• Immune thrombocytopenia (ITP) is an autoantibody-mediated platelet disorder lacking reliable bleeding risk biomarkers.

Purpose of the Study:

• Introduce "single cell immuno-mechanical modulation" linking immunology and cellular mechanics.
• Investigate platelet mechanics as a biomarker for bleeding risk in pediatric ITP patients.

Main Methods:

• Utilized micropatterned hydrogel-laden coverslips for clinical mechanobiology studies.
• Employed standard fluorescence microscopy to analyze single platelet contraction force.
• Studied pediatric ITP patients (n=53) and healthy controls.

Main Results:

• Low single platelet contraction force identified as a physics-based biomarker for bleeding in pediatric ITP (92.3% sensitivity, 90% specificity).
• Autoantibodies and monoclonal antibodies alter cell force by stabilizing integrins in specific conformations.
• Demonstrated immuno-mechanical modulation's role in antibody-induced mechanotransduction alterations.

Conclusions:

• Single cell immuno-mechanical modulation provides a framework for understanding antibody-driven disease pathophysiology.
• Platelet contraction force is a promising biomarker for predicting bleeding risk in ITP.
• This phenomenon offers potential for controlling cellular mechanics in research, diagnostics, and therapeutics.